Arnatar Therapeutics

Arnatar is reimagining RNA medicines to precisely silence disease drivers or restore what’s missing. Through their dual-modality DARGER™ platform, they develop best-in-class siRNA and first-in-class upregulating ASOs for cardiometabolic, liver, CNS, and kidney diseases.